The Evidence Based Rheumatology Podcast
Health & Fitness:Medicine
Trying to get to IL6, but so much happening in the world of hydroxychloroquine. As I said at the beginning, things are likely to move fast. I'm planning to make this as an extended series, so please go back and listen to #1 before you listen to this! This episode will round out the paper by Gautret et al. and discuss the best copy of a paper by Jun et al. that I've been able to find. Follow me @ebrheum and share with friends!
E111: PEXIVAS Subsets with Mike Walsh & Mats Junek
E110: Rheum4Debate - Screening for RA-ILD with Joshua Solomon and Scott Matson
E109: Abatacept for Pre-RA - the ARIAA Study
E108: Myositis Guidelines for Cancer Screening w/Alexander Oldroyd
E107: Fragility of SLE Randomized Controlled Trials
E106: GCA/PMR with Bhaskar Dasgupta
E105: Autoimmunity Post COVID-19?
E104: Sarilumab for PMR - The SAPHYR Study
E103: Len Calabrese on Monoclonal Antibodies for COVID-19
E102: Unintentional Unblinding in Rheumatic Disease Trials
E101: Pred v Colchicine for CPPD: COLCHICORT
E100: ADVOCATE Health Related Quality of Life
E99: Hospital Problems
E98: Key Opinion Leaders & ILD Guidelines
E97: Does allopurinol reduce CVD? The ALLHEART Study
E96: Long COVID - Where to After Norway?
E95: Rituximab or Cyclophosphamide in ANCA Vasculitis
E94: Steroids and Psoriasis Flares
E93: Azathioprine is the Worst
E92: Are muscle symptoms from statins imaginary?
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Peter Attia Drive
The Doctor’s Farmacy with Mark Hyman, M.D.